Work

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

Year: 2001

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: J Banchereau, A K Palucka, M Dhodapkar, S Burkeholder, N Taquet, A Rolland, S Taquet, S Coquery, K M Wittkowski, N Bhardwaj, L Pineiro, R Steinman, J Fay

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: EBV SPECIFIC THERAPY OF LYMPHOMA USING DENDRITIC CELLS, GENERAL CLINICAL RESEARCH CENTER, Improving the Efficacy of Dendritic Cell Vaccines, Subpopulations of Human Dendritic Cells

OpenAlex ID: W2099515509

FWCI: 26.6

Cites: 32

Cited by: 811

Related to: 10